Yong Kai Wong, general counsel of CITIC Capital Holdings, explains how the Chinese government faces challenges in striking a balance between developing the domestic capital markets and responding to the country's evolving economic model
Features & Analyses
- August 01, 2014
The CIRC has made it easier for insurance companies to engage in M&A. Although the Commission maintains a strict supervisory role in transactions, its motive for deregulation is clear. More reforms are in the pipeline for this complex and competitive market
July 16, 2014Though the revised Trademark Law has made substantial improvements, protection and enforcement tactics against trademark squatters still remain crucial in the IP environment of China
July 11, 2014Awareness of local courts and judges' practices as well as understanding of the laws, judicial trends and case outcomes are critical for MNCs' IP protection in China
July 11, 2014The Supreme People's Court has released its report on the leading IP cases of 2013. The judges have clarified some issues but left important questions about the new procedural rules unanswered
July 11, 2014The new Implementing Regulations fail to pick up on the many issues raised by the revised Trademark Law, such as clarifying OEM limits, enforcing against those who facilitate infringement, calculating illegal operations and questioning the legitimacy of “good faith” sellers, says Jack Chang
July 11, 2014I am looking to set up my business in China. There are many concerns among foreign investors regarding both onshore and offshore franchising. Should I enter into a direct contract with a local entity or form a joint venture? How do I ensure my assets will be protected?
July 10, 2014The Environmental Protection Law has just been amended for the first time after 25 years. Conducting environmental due diligence and establishing an image of integrity are more important than ever for foreign enterprises
July 08, 2014The Environmental Protection Law has just been amended for the first time after 25 years. Conducting environmental due diligence and establishing an image of integrity are more important than ever for foreign enterprises
July 08, 2014GlaxoSmithKline is facing serious charges of misconduct as enforcement grows fierce. The entwining Chinese anti-bribery laws, the US FCPA and UK Bribery Act call for immediate attention to risks and compliance on both a national and global scale
July 08, 2014
